Obeidat, Ma’en http://orcid.org/0000-0002-5443-2752
Zhou, Guohai
Li, Xuan
Hansel, Nadia N.
Rafaels, Nicholas
Mathias, Rasika
Ruczinski, Ingo
Beaty, Terri H.
Barnes, Kathleen C.
Paré, Peter D.
Sin, Don D.
Article History
Received: 16 January 2018
Accepted: 27 March 2018
First Online: 10 April 2018
Ethics approval and consent to participate
: Work undertaken in this manuscript was approved by the University of British Columbia Institutional Review Board, certificate numberH16–01201.
: Not applicable.
: Dr. Sin has received research funding from AstraZeneca (AZ), Merck, Boehringer Ingelheim (BI) and Novartis and has received honorarium for speaking engagements from AZ, Novartis, Regeneron and Sanofi-Aventis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.